(Press-News.org) SAN ANTONIO — June 17, 2024 —Southwest Research Institute (SwRI) today celebrated the groundbreaking of the Center for Accelerating Materials and Processes (CAMP), a new facility that will support research and development for tomorrow’s high-speed aerospace engines.
“This project will help ensure the U.S. is a leader in high-speed propulsion research and development,” said Dr. Barron Bichon, director of SwRI’s Materials Engineering Department. “SwRI is committed to advancing this vital technology on behalf of Texas and the nation.”
Market forces including growth in global defense, air travel, delivery and transportation needs are driving the demand for high-speed engines. Initial projects in the new CAMP facility will focus on demonstrating faster, more efficient techniques for manufacturing high-speed propulsion systems.
Once construction on the new two-story, 36,600 square-foot facility is complete, SwRI will begin evaluating new materials and processes designed to produce a high-speed engine in a considerably shorter amount of time than current production timelines.
“This new facility will see the development of innovative technology that reflects SwRI’s mission of serving humankind,” said Dr. Ben Thacker, vice president of SwRI’s Mechanical Engineering Division. “Advancing high-speed propulsion systems propels us toward a future with stronger defense capabilities and greater global connectivity.”
One of the CAMP facility’s initial projects will involve procuring and installing manufacturing process test equipment. Under a contract from the Office of the Secretary of Defense’s Manufacturing Science and Technology Program, SwRI engineers will demonstrate how the facility will reduce production times and costs. The Institute will invest $34 million in the construction of the CAMP facility.
For more information, visit https://www.swri.org/technical-divisions/mechanical-engineering.
END
SwRI breaks ground on new hypersonic engine research facility
Institute will demonstrate faster methods of producing high-speed propulsion systems
2024-06-17
ELSE PRESS RELEASES FROM THIS DATE:
International Gemini Observatory and Subaru combine forces to discover first ever pair of merging quasars at cosmic dawn
2024-06-17
Since the very first instant after the Big Bang the Universe has been expanding. This means that the early Universe was considerably smaller and early-formed galaxies were more likely to interact and merge. Galaxy mergers fuel the formation of quasars — extremely luminous galactic cores where gas and dust falling into a central supermassive black hole emit enormous amounts of light. So when looking back at the early Universe astronomers would expect to find numerous pairs of quasars in close proximity to each other as their host galaxies undergo mergers. However, they have been surprised ...
Repurposed drug may help stabilize vision in rare disease
2024-06-17
Roughly 50 families scattered across the world share ultra-rare variants in a particular gene. Silent for years, the inherited mutations make themselves known when patients reach the fourth decade of life. Changes in vision start a cascade of symptoms. Five to 20 years later, the illness is fatal.
Researchers at Washington University School of Medicine in St. Louis have dedicated many years to understanding the rare condition known as retinal vasculopathy with cerebral leukoencephalopathy and systemic manifestations, or RVCL-S, with the aim of developing a treatment ...
Face screening tool detects stroke in seconds
2024-06-17
A new smartphone face-screening tool could help paramedics to identify stroke in seconds – much sooner and more accurately than is possible with current technologies.
Strokes, which affect millions of people globally, occur when the blood supply to part of the brain is interrupted or reduced, which prevent brain tissue from getting oxygen and nutrients. A few minutes of delay can result in permanent damage to the brain cells.
A team of biomedical engineers at RMIT University developed the AI capabilities behind the software technology and has published their results ...
Making this Parkinson's drug is just turtles all the way down (video)
2024-06-17
WASHINGTON, June 17, 2024 — L-DOPA is the best drug we have for Parkinson’s disease, but its molecular mirror image, D-DOPA, causes dangerous side effects. Making L-DOPA without also making D-DOPA is surprisingly hard and requires a specific kind of molecule to pull off. But that specific molecule must be made from a different and equally specific molecule. In this video, our host, George Zaidan, explains how one of the winners of the 2001 Nobel Prize in Chemistry pulled it off, and why "chiral synthesis," as it's called, is really just turtles all the way down. https://youtu.be/_cb09XB07LQ?si=BuMEI5fOuHmuQlkZ
Reactions is a video series ...
Camelid nanobodies: Transforming food allergen analysis
2024-06-17
Recent advancements show nanobodies from camelid antibodies excel in food allergen detection with superior stability, specificity, and cost-effectiveness. This innovative approach aims to improve accuracy and efficiency, crucial for preventing severe allergic reactions. The study highlights nanobodies' potential in reliable immunoassays, addressing rising food allergies and enhancing safety measures.
Food allergies pose significant health risks, affecting millions worldwide, with the prevalence rising over the past decades. Traditional detection methods, such as monoclonal and polyclonal antibodies, are often costly, labor-intensive, and prone to cross-reactions. The need for ...
Federal study examines care following nonfatal overdose among Medicare beneficiaries; identifies effective interventions and gaps in care
2024-06-17
Researchers from the Substance Abuse and Mental Health Services Administration (SAMHSA), the National Institutes of Health’s (NIH) National Institute on Drug Abuse (NIDA), Centers for Medicare & Medicaid Services (CMS), and the Centers for Disease Control and Prevention (CDC) found that among a cohort of 137,000 Medicare beneficiaries who experienced a nonfatal overdose in 2020, almost 24,000 (17.4%) experienced a subsequent nonfatal overdose, and about 1,300 (1%) died from overdose in the following year. Results were published today in JAMA Internal Medicine, identifying both effective interventions and significant gaps in care.
“People who have experienced ...
Maternal inheritance of Alzheimer’s disease tied to increased risk of developing disease
2024-06-17
KEY TAKEAWAYS
Mass General Brigham researchers analyzed 4,400 cognitively unimpaired adults with amyloid imaging, finding increased amyloid in those who reported that their mothers had symptoms of Alzheimer’s disease (AD).
Increased amyloid, a biomarker of AD, was also found in those with a history of the disease on both sides of their family and in those whose fathers had an early onset of symptoms.
The study suggests that a person’s maternal versus paternal family history could ...
Epidemiologic features of recovery from SARS-CoV-2 infection
2024-06-17
About The Study: More than 1 in 5 adults did not recover within 3 months of SARS-CoV-2 infection in this cohort study. Recovery within 3 months was less likely in women and those with preexisting cardiovascular disease and more likely in those with COVID-19 vaccination or infection during the Omicron variant wave.
Corresponding Author: To contact the corresponding author, Elizabeth C. Oelsner, M.D., M.P.H., email eco7@cumc.columbia.edu.
To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/
(doi:10.1001/jamanetworkopen.2024.17440)
Editor’s Note: Please see the article for additional information, ...
Electronic cigarettes vs varenicline for smoking cessation in adults
2024-06-17
About The Study: This randomized clinical trial found that varenicline and nicotine-containing electronic cigarettes were both effective in helping individuals in quitting smoking conventional cigarettes for up to 6 months.
Corresponding Author: To contact the corresponding author, Anna Tuisku, Ph.D., email anna.tuisku@lapha.fi.
To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/
(doi:10.1001/jamainternmed.2024.1822)
Editor’s Note: Please see the article ...
Risk factors for long COVID revealed
2024-06-17
NEW YORK, NY (June 14, 2024)--Early in the pandemic, many people who had SARS-Cov-2 infection or COVID-19 began to report that they couldn’t shake off their symptoms even after a month or more—unusually long for a viral infection of the upper respiratory tract—or developed new, persistent symptoms soon after the infection cleared.
Although it’s still not clear what causes post-COVID-19 conditions or “long COVID” (symptoms and conditions that develop, linger, or reoccur weeks or months after SARS-CoV-2 infection), a new study by researchers at Columbia University Vagelos College ...
LAST 30 PRESS RELEASES:
Making lighter work of calculating fluid and heat flow
Normalizing blood sugar can halve heart attack risk
Lowering blood sugar cuts heart attack risk in people with prediabetes
Study links genetic variants to risk of blinding eye disease in premature infants
Non-opioid ‘pain sponge’ therapy halts cartilage degeneration and relieves chronic pain
AI can pick up cultural values by mimicking how kids learn
China’s ecological redlines offer fast track to 30 x 30 global conservation goal
Invisible indoor threats: emerging household contaminants and their growing risks to human health
Adding antibody treatment to chemo boosts outcomes for children with rare cancer
Germline pathogenic variants among women without a history of breast cancer
Tanning beds triple melanoma risk, potentially causing broad DNA damage
Unique bond identified as key to viral infection speed
Indoor tanning makes youthful skin much older on a genetic level
Mouse model sheds new light on the causes and potential solutions to human GI problems linked to muscular dystrophy
The Journal of Nuclear Medicine ahead-of-print tip sheet: December 12, 2025
Smarter tools for peering into the microscopic world
Applications open for funding to conduct research in the Kinsey Institute archives
Global measure underestimates the severity of food insecurity
Child survivors of critical illness are missing out on timely follow up care
Risk-based vs annual breast cancer screening / the WISDOM randomized clinical trial
University of Toronto launches Electric Vehicle Innovation Ontario to accelerate advanced EV technologies and build Canada’s innovation advantage
Early relapse predicts poor outcomes in aggressive blood cancer
American College of Lifestyle Medicine applauds two CMS models aligned with lifestyle medicine practice and reimbursement
Clinical trial finds cannabis use not a barrier to quitting nicotine vaping
Supplemental nutrition assistance program policies and food insecurity
Switching immune cells to “night mode” could limit damage after a heart attack, study suggests
URI-based Global RIghts Project report spotlights continued troubling trends in worldwide inhumane treatment
Neutrophils are less aggressive at night, explaining why nighttime heart attacks cause less damage than daytime events
Menopausal hormone therapy may not pose breast cancer risk for women with BRCA mutations
Mobile health tool may improve quality of life for adolescent and young adult breast cancer survivors
[Press-News.org] SwRI breaks ground on new hypersonic engine research facilityInstitute will demonstrate faster methods of producing high-speed propulsion systems







